BRIEF

on Temedica GmbH

Temedica and Roche Expand Partnership with Digital Health Innovations

Temedica and Roche are expanding their successful collaboration, focusing on digital patient companion apps. Since the collaboration's inception, these apps have supported a significant number of patients. This partnership is set to enhance patient care through technological innovation.

The apps, Retinora and Brisa, focus on specific medical conditions. Retinora targets conditions like macular degeneration, while Brisa serves individuals with multiple sclerosis. The success of Brisa has led to its fifth-anniversary celebration and further expansion, including the growth of the “OcreKompass” service.

The apps leverage Temedica’s platform technology, providing personalized support and incorporating insights from real-world data. They offer users the chance to contribute to scientific research, maintaining user privacy in compliance with GDPR regulations.

R. E.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Temedica GmbH news